Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Am Surg ; 85(5): 505-510, 2019 May 01.
Article in English | MEDLINE | ID: mdl-31126364

ABSTRACT

Chest radiographs (CXRs) and laboratory testing have historically been performed as a part of low-risk melanoma (clinical stage 1/2) workup. This study evaluates the utility of routine CXRs and laboratory testing during the staging of clinical stage 1 and 2 melanoma patients. This study was approved by the Institutional Review Board at Wake Forest University. A database of sentinel lymph node biopsies performed for clinical stage 1 or 2 melanoma was used to identify early-stage melanoma patients. The medical records of patients with melanoma were reviewed and preoperative workup procedures were recorded. Four hundred sixty-three patients were reviewed. A total of 315 patients underwent a preoperative CXR, whereas 309 received some laboratory testing. After sentinel node biopsies, 168 patients had pathologic stage 1 disease, 103 stage 2, and 44 stage 3. None of the CXRs (0%) correctly identified metastatic melanoma. Suspicious locations on CXRs and laboratory testing did not lead to metastatic findings in any patient within a year. Metastatic melanoma was not found in any patient by screening with CXRs or laboratory testing during preoperative workup. We recommend not conducting CXRs or laboratory testing during workup for surgical melanoma patients because of charges and anxiety these tests can cause. CXRs, blood tests, and metabolic panels have historically been ordered for early melanoma patients, although debate remains on their efficacy. Surgical patient records were retrospectively reviewed for these tests and no benefit was found.


Subject(s)
Melanoma/diagnostic imaging , Melanoma/secondary , Radiography, Thoracic , Skin Neoplasms/diagnostic imaging , Adult , Aged , Diagnostic Tests, Routine , Female , Humans , Male , Melanoma/surgery , Middle Aged , Neoplasm Staging , Predictive Value of Tests , Retrospective Studies , Sentinel Lymph Node Biopsy , Skin Neoplasms/pathology , Skin Neoplasms/surgery
2.
Magn Reson Chem ; 55(7): 670-676, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28024162

ABSTRACT

Analysis of complex mixtures is a common challenge in natural products research. Quantitative nuclear magnetic resonance spectroscopy offers analysis of complex mixtures at early stages and with benefits that are orthogonal to more common methods of quantitation, including ultraviolet absorption spectroscopy and mass spectrometry. Several experiments were conducted to construct a methodology for use in analysis of extracts of fungal cultures. A broadly applicable method was sought for analysis of both pure and complex samples through use of an externally calibrated method. This method has the benefit of not contaminating valuable samples with the calibrant, and it passed scrutiny for line fitting and reproducibility. The method was implemented to measure the yield of griseofulvin and dechlorogriseofulvin from three fungal isolates. An isolate of Xylaria cubensis (coded MSX48662) was found to biosynthesize griseofulvin in the greatest yield, 149 ± 8 mg per fermentation, and was selected for further supply experiments. Copyright © 2016 John Wiley & Sons, Ltd.


Subject(s)
Biological Products/analysis , Fungi/metabolism , Magnetic Resonance Spectroscopy/methods , Anthraquinones/analysis , Anthraquinones/metabolism , Ascomycota/chemistry , Ascomycota/metabolism , Biological Products/metabolism , Fermentation , Fungi/chemistry , Griseofulvin/analysis , Griseofulvin/metabolism , Metabolomics , Reproducibility of Results , Secondary Metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...